Home  >  Products  >  MAPK13 (mitogen-activated protein kinase 13) Blocking Peptide (the middle region of MAPK13)(100ug)
MAPK13 (mitogen-activated protein kinase 13) Blocking Peptide (the middle region of MAPK13)(100ug)

MAPK13 (mitogen-activated protein kinase 13) Blocking Peptide (the middle region of MAPK13)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MAPK13 Antibody(ARP56439_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP56439
Size: 100ug
Weight: 42kDa
Gene: 5603
Format: Lyophilized powder
Target: The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is closely related to p38 MAP kinase, both of which can be activated by proinflammatory cytokines and cellular stress. MAP kinase kinases 3, and 6 can phosphorylate and activate this kinase. Transcription factor ATF2, and microtubule dynamics regulator stathmin have been shown to be the substrates of this kinase.
Alternative names: MGC99536; PRKM13; SAPK4; p38delta
See Full Product Listings >